Compare Figure Technology Solutions Inc. Class A Common Stock (FIGR) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figure Technology Solutions Inc. Class A Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Figure Technology Solutions Inc. Class A Common Stock trades at $28.54 (market cap $6.19B), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2× Figure Technology Solutions Inc. Class A Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Figure Technology Solutions Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Figure Technology Solutions Inc. Class A Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| FIGR | HALO | |
|---|---|---|
Market Cap | $6.19B | $12.58B |
Volume | 4,762,342 | 2,179,278 |
Sector | Financials | Health |
52-Week High | $73.91 | $115.22 |
52-Week Low | $24.91 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $6.23B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Figure Technology Solutions Inc. Class A Common Stock
Figure Technology Solutions operates a blockchain-native capital marketplace. Its platform supports loan origination, funding, sale, and trading of tokenized assets, along with digital-asset infrastructure and services.
Read more on FIGR →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
